Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
52.00
+1.48 (2.93%)
Feb 25, 2026, 3:41 PM EST - Market open
Moderna Market Cap
Moderna has a market cap or net worth of $20.54 billion as of February 25, 2026. Its market cap has increased by 63.70% in one year.
Market Cap
20.54B
Enterprise Value
13.89B
1-Year Change
63.70%
Ranking
Category
Stock Price
$52.00
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $20.54B, an increase of 235.66%. That is a compound annual growth rate of 18.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 19.95B | 73.16% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNTech SE | 27.82B |
| Royalty Pharma | 26.19B |
| Revolution Medicines | 20.27B |
| Roivant Sciences | 20.23B |
| Incyte | 20.11B |
| Genmab | 17.99B |
| Ascendis Pharma | 14.42B |
| Ionis Pharmaceuticals | 13.84B |